Literature DB >> 6512819

Antiviral treatment of chronic hepatitis B virus infection.

D M Novick, H C Thomas.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6512819      PMCID: PMC1440159          DOI: 10.1177/014107688407701202

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  20 in total

1.  Thymidine kinase from herpes simplex virus phosphorylates the new antiviral compound, 9-(2-hydroxyethoxymethyl)guanine.

Authors:  J A Fyfe; P M Keller; P A Furman; R L Miller; G B Elion
Journal:  J Biol Chem       Date:  1978-12-25       Impact factor: 5.157

2.  Natural history of liver disease in chronic hepatitis B surface antigen carriers. Survey of 100 patients from Great Britain.

Authors:  L A Viola; I G Barrison; J C Coleman; F J Paradinas; J L Fluker; B A Evans; I M Murray-Lyon
Journal:  Lancet       Date:  1981-11-21       Impact factor: 79.321

3.  The British Society of Gastroenterology. 25-27 April 1984, Salford. Abstracts.

Authors: 
Journal:  Gut       Date:  1984-05       Impact factor: 23.059

4.  Thrice weekly lymphoblastoid interferon is effective in inhibiting hepatitis B virus replication.

Authors:  A S Lok; I V Weller; P Karayiannis; D Brown; M J Fowler; J Monjardino; H C Thomas; S Sherlock
Journal:  Liver       Date:  1984-02

5.  HBsAg-positive chronic liver disease: inhibition of DNA polymerase activity by vidarabine.

Authors:  R G Chadwick; M F Bassendine; E M Crawford; H C Thomas; S Sherlock
Journal:  Br Med J       Date:  1978-08-19

6.  Antiviral treatment of chronic hepatitis B virus infection. I. Changes in viral markers with interferon combined with adenine arabinoside.

Authors:  G H Scullard; R B Pollard; J L Smith; S L Sacks; P B Gregory; W S Robinson; T C Merigan
Journal:  J Infect Dis       Date:  1981-06       Impact factor: 5.226

7.  Effects of prednisolone/azathioprine in chronic hepatitis B viral infection.

Authors:  I V Weller; M F Bassendine; A K Murray; A Craxi; H C Thomas; S Sherlock
Journal:  Gut       Date:  1982-08       Impact factor: 23.059

8.  Adenine arabinoside therapy in HBsAg-positive chronic liver disease: a controlled study.

Authors:  M F Bassendine; R G Chadwick; J Salmeron; U Shipton; H C Thomas; S Sherlock
Journal:  Gastroenterology       Date:  1981-05       Impact factor: 22.682

9.  Diminished responsiveness of homosexual men to antiviral therapy for HBsAg-positive chronic liver disease.

Authors:  D M Novick; A S Lok; H C Thomas
Journal:  J Hepatol       Date:  1985       Impact factor: 25.083

10.  Double-blind study of leucocyte interferon administration in chronic HBsAg-positive hepatitis.

Authors:  W Weimar; R A Heijtink; F J ten Kate; S W Schalm; N Masurel; H Schellekens; K Cantell
Journal:  Lancet       Date:  1980-02-16       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.